Characterization and clinical impact of antinuclear antibodies in primary biliary cirrhosis

American Journal of Gastroenterology

Volumn 98, Issue 2, 2003, Pages 431-437

  Muratori, Paolo ^a   Muratori, Luigi ^b   Ferrari, Rodolfo ^b   Cassani, Fabio ^b   Bianchi, Giampaolo ^b   Lenzi, Marco ^b   Rodrigo, Luis ^b   Linares, Antonio ^b   Fuentes, Dolores ^b   Bianchi, Francesco B ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIGEN; CELL NUCLEUS ANTIGEN; MITOCHONDRION ANTIBODY;

ADULT; AGED; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; BILIARY CIRRHOSIS; CONTROLLED STUDY; COUNTER IMMUNOELECTROPHORESIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; IMMUNOBLOTTING; IMMUNOFLUORESCENCE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL;

EID: 0037283230     PISSN: 00029270     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1572-0241.2003.07257.x     Document Type: Article

References (42)

1. Kaplan MM. Primary biliary cirrhosis. N Engl J Med 1996; 335:1570-80.
2. Bernstein RM, Neuberger JM, Bunn CC, et al. Diversity of autoantibodies in primary biliary cirrhosis and chronic active hepatitis. Clin Exp Immunol 1984;55:553-60.
3. Lozano F, Pares A, Borche L, et al. Autoantibodies against nuclear envelope-associated proteins in primary biliary cirrhosis. Hepatology 1988;8:930-8.
4. Lassoued K, Brenard R, Degos F, et al. Antinuclear antibodies directed to a 200-kilodalton polypeptide of the nuclear envelope in primary biliary cirrhosis. A clinical and immunological study of a series of 150 patients with primary biliary cirrhosis. Gastroenterology 1990;99:181-6.
5. Courvalin JC, Lassoued K, Bartnik E, et al. The 210-kD nuclear envelope polypeptide recognized by human autoantibodies in primary biliary cirrhosis is the major glycoprotein of the nuclear pore. J Clin Invest 1990;86:279-85.
6. Courvalin JC, Lassoued K, Worman HJ, et al. Identification and characterization of autoantibodies against the nuclear envelope lamin B receptor from patients with primary biliary cirrhosis. J Exp Med 1990;172:961-7.
7. Powell F, Schroeter AL, Dickson ER. Antinuclear antibodies in primary biliary cirrhosis. Lancet 1984;1:288-9.
8. Fritzler MJ, Valencia DW, McCarty GA. Speckled pattern antinuclear antibodies resembling anticentromere antibodies. Arthritis Rheum 1984;27:92-6.
9. Szostecki C, Krippner H, Penner E, et al. Autoimmune sera recognize a 100 kD nuclear protein antigen (sp-100). Clin Exp Immunol 1987;68:108-16.
10. Sternsdorf T, Guldner HH, Szostecki C, et al. Two nuclear dot-associated proteins, PML and Sp100, are often co-autoimmunogenic in patients with primary biliary cirrhosis. Scand J Immunol 1995;42:257-68.
11. Guldner HH, Szostecki C, Schroder P, et al. Splice variants of the nuclear dot-associated Sp100 protein contain homologies to HMG-1 and a human nuclear phosphoprotein-box motif. J Cell Sci 1999;112:733-47.
12. Dyck JA, Maul GG, Miller WH, Jr, et al. A novel macromolecular structure is a target of the promyelocyte-retinoic acid receptor oncoprotein. Cell 1994;76:333-43.
13. Pante N, Aebi U. The nuclear pore complex. J Cell Biol 1993;122:977-84.
14. Wozniak RW, Bartnik E, Blobel G. Primary structure analysis of an integral membrane glycoprotein of the nuclear pore. J Cell Biol 1989;108:2083-92.
15. Lassoued K, Danon F, Brouet JC. Human autoantibodies to lamin B receptor are also anti-idiotypic to certain anti-lamin B antibodies. Eur J Immunol 1991;21:1959-62.
16. Wesierska-Gadek J, Hohenuer H, Hitchman E, et al. Autoantibodies against nucleoporin p62 constitute a novel marker of primary biliary cirrhosis. Gastroenterology 1996;110:840-7.
17. Szostecki C, Guldner HH, Will H. Autoantibodies against "nuclear dots" in primary biliary cirrhosis. Semin Liver Dis 1997;17:71-8.
18. Nickowitz RE, Wozniak RW, Schaffner F, et al. Autoantibodies against integral membrane proteins of the nuclear envelope in patients with primary biliary cirrhosis. Gastroenterology 1994;106:193-9.
19. Bandin O, Courvalin JC, Poupon R, et al. Specificity and sensitivity of gp210 autoantibodies detected using an enzymelinked immunosorbent assay and a synthetic polypeptide in the diagnosis of primary biliary cirrhosis. Hepatology 1996;23: 1020-4.
20. Alvarez F, Berg P, Bianchi F, et al. International Autoimmune Hepatitis Group Report: Review of criteria for diagnosis of autoimmune hepatitis. J Hepatol 1999;31:929-38.
21. Dickson ER, Grambsch PM, Fleming TR, et al. Prognosis in primary biliary cirrhosis: Model for decision making. Hepatology 1989;10:1-7.
22. Muratori P, Muratori L, Cassani F, et al. Anti-multiple nuclear dots (anti-MND) and anti-SP100 antibodies in hepatic and rheumatological disorders. Clin Exp Immunol 2002;127:172-5.
23. Zauli D, Ghetti S, Grassi A, et al. Anti-neutrophil cytoplasmic antibodies in type 1 and 2 autoimmune hepatitis. Hepatology 1997;25:1105-7.
24. Bernstein RM, Bunn CC, Hughes GR. Identification of antibodies to acidic antigens by counterimmunoelectrophoresis. Ann Rheum Dis 1982;41:554-5.
25. Cassani F, Fusconi M, Bianchi FB, et al. Precipitating antibodies to rabbit thymus extractable antigens in chronic liver disease: Relationship with anti-actin antibodies. Clin Exp Immunol 1987;68:588-95.
26. ILAR/IUIS International Committee, Tan EM, Feltkamp TEW, et al. Reference reagents for antinuclear antibodies. Arthritis Rheum 1988;31:1331.
27. Bottazzo GF, Florin-Christensen A, Fairfax A, et al. Classification of smooth muscle autoantibodies detected by immunofluorescence. J Clin Pathol 1976;29:403-10.
28. Itoh S, Ichida T, Yoshida T, et al. Autoantibodies against a 210 kDa glycoprotein of the nuclear pore complex as a prognostic marker in patients with primary biliary cirrhosis. J Gastroenterol Hepatol 1998;13:257-65.
29. Invernizzi P, Podda M, Battezzati PM, et al. Autoantibodies against nuclear pore complexes are associated with more active and severe liver disease in primary biliary cirrhosis. J Hepatol 2001;34:366-72.
30. Kaplan MM. The use of methotrexate, colchicine, and other immunomodulatory drugs in the treatment of primary biliary cirrhosis. Semin Liver Dis 1997;17:129-36.
31. Ben-Ari Z, Dhillon AP, Sherlock S. Autoimmune cholangiopathy: Part of the spectrum of autoimmune chronic active hepatitis. Hepatology 1993;18:10-5.
32. Michieletti P, Wanless IR, Katz A, et al. Antimitochondrial antibody negative primary biliary cirrhosis: A distinct syndrome of autoimmune cholangitis. Gut 1994;35:260-5.
33. Goodman ZD, McNally PR, Davis DR, et al. Autoimmune cholangitis: A variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases. Dig Dis Sci 1995;40:1232-42.
34. Sanchez-Pobre P, Castellano G, Colina F, et al. Antimitochondrial antibody-negative chronic nonsuppurative destructive cholangitis. Atypical primary biliary cirrhosis or autoimmune cholangitis? J Clin Gastroenterol 1996;23:191-8.
35. Heathcote J. Autoimmune cholangitis. Gut 1997;40:440-2.
36. Kinoshita H, Omagari K, Whittingham S, et al. Autoimmune cholangitis and primary biliary cirrhosis - an autoimmune enigma. Liver 1999;19:122-8.
37. Miyakawa H, Kawaguchi N, Kikuchi K, et al. Definition of antigen specificity for antimitochondrial proteins detected by Western blotting using native mitochondrial proteins in primary biliary cirrhosis. Hepatol Res 2001;21:101-7.
38. Miyakawa H, Tanaka A, Kikuchi K, et al. Detection of antimitochondrial autoantibodies in immunofluorescent AMAnegative patients with primary biliary cirrhosis using recombinant autoantigens. Hepatology 2001;34:243-8.
39. Gordon SC, Quattrociocchi-Longe TM, Khan BA, et al. Antibodies to carbonic anhydrase in patients with immune cholangiopathies. Gastroenterology 1995;108:1802-9.
40. Muratori P, Muratori L, Lenzi M, et al. Antibodies to carbonic anhydrase in autoimmune cholangiopathy. Gastroenterology 1997;112:1053-4.
41. Invernizzi P, Battezzati PM, Crosignani A, et al. Antibody to carbonic anhydrase II is present in primary biliary cirrhosis (PBC) irrespective of antimitochondrial antibody status. Clin Exp Immunol 1998;114:448-54.
42. Akisawa N, Nishimori I, Miyaji E, et al. The ability of anticarbonic anhydrase II antibody to distinguish autoimmune cholangitis from primary biliary cirrhosis in Japanese patients. J Gastroenterol 1999;34:366-71.